CARLSBAD, Calif., April 3, 2017 /PRNewswire/ -- Natural
Alternatives International, Inc. ("NAI") (NASDAQ: NAII), a leading
formulator, manufacturer and marketer of customized nutritional
supplements, announced today that the U.S. Patent and Trademark
Office has issued a Notice of Allowance of a patent application
directed to a broad range of improved methods of beta-alanine
intake. These 28 allowed patent claims target such benefits
as delaying muscle fatigue, increasing anaerobic capacity,
increasing muscle strength and increasing muscle endurance. This
patent when issued will not only become part of NAI's extensive
global portfolio covering its CarnoSyn® beta-alanine and
SR CarnoSyn® product, but more importantly,
significantly lengthens the patent coverage around its original
CarnoSyn® beta-alanine to 2023. Following this
Notice of Allowance NAI intends to seek a significant number of
additional patent claims to further broaden its intellectual
property protection.
Mark A. LeDoux, NAI's CEO and
Chairman of the Board, said that "NAI is very excited by the
addition of this important intellectual property related to a broad
range of improved methods of beta-alanine intake. We believe
this new patent continues to strengthen our worldwide portfolio of
intellectual property related to our branded CarnoSyn®
beta-alanine. Moreover, these patent rights will not expire
until 2023, which gives NAI and its dedicated licensees the benefit
of offering products that include CarnoSyn® beta-alanine
and the patent portfolio surrounding it. These new patent
rights further demonstrate our commitment and significant
investment in the CarnoSyn® beta-alanine business."
NAI, headquartered in Carlsbad,
California, is a leading formulator, manufacturer and
marketer of nutritional supplements and provides strategic
partnering services to its customers. NAI's comprehensive
partnership approach offers a wide range of innovative nutritional
products and services to NAI's clients including: scientific
research, clinical studies, proprietary ingredients,
customer-specific nutritional product formulation, product testing
and evaluation, marketing management and support, packaging and
delivery system design, regulatory review and international product
registration assistance. For more information about NAI, please see
its website at http://www.nai-online.com.
This press release contains forward-looking statements within
the meaning of applicable securities laws that are not historical
facts and information. These statements represent our intentions,
expectations and beliefs concerning future events, including, among
other things, our expectations and beliefs with respect to our
intellectual property rights and the potential expansion thereof,
the outcome of pending litigation, the continued validity of our
patents, and our ability to successfully develop, license and
enforce our intellectual property rights. We wish to caution
readers these statements involve risks and uncertainties that could
cause actual results and outcomes for future periods to differ
materially from any forward-looking statement or views expressed
herein. NAI's financial performance and the forward-looking
statements contained herein are further qualified by other risks
including those set forth from time to time in the documents filed
by us with the Securities and Exchange Commission, including our
most recent Annual Report on Form 10-K and Quarterly Report on Form
10-Q.
CONTACT – Kenneth Wolf, President
and Chief Operating Officer, Natural Alternatives International,
Inc., at 760-736-7700 or investor@nai-online.com.
Web site: http://www.nai-online.com/
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/natural-alternatives-international-inc-announces-extension-of-carnosyn-beta-alanine-intellectual-property-portfolio-300432972.html
SOURCE Natural Alternatives International, Inc.